These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 29292855)

  • 1. Molecular basis of complement factor I deficiency in Tunisian atypical haemolytic and uraemic syndrome patients.
    Jlajla H; Dehman F; Jallouli M; Khedher R; Ayadi I; Zerzeri Y; Laadhar L; Sfar I; Mahfoudh A; Gorgi Y; Cheour E; Zouaghi K; Gargah T; Kallel Sellami M
    Nephrology (Carlton); 2019 Mar; 24(3):357-364. PubMed ID: 29292855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular basis and outcomes of atypical haemolytic uraemic syndrome in Czech children.
    Štolbová Š; Bezdíčka M; Seeman T; Prohászka Z; Csuka D; Hrachovinová I; Burkert J; Šimánková N; Průhová Š; Zieg J
    Eur J Pediatr; 2020 Nov; 179(11):1739-1750. PubMed ID: 32424742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An ELISA assay with two monoclonal antibodies allows the estimation of free factor H and identifies patients with acquired deficiency of this complement regulator.
    Nozal P; Garrido S; Alba-Domínguez M; Espinosa L; Peña A; Córdoba SR; Sánchez-Corral P; López-Trascasa M
    Mol Immunol; 2014 Apr; 58(2):194-200. PubMed ID: 24378252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic analysis and functional characterization of novel mutations in a series of patients with atypical hemolytic uremic syndrome.
    Szarvas N; Szilágyi Á; Csuka D; Takács B; Rusai K; Müller T; Arbeiter K; Réti M; Haris Á; Wagner L; Török S; Kelen K; Szabó AJ; Reusz GS; Morgan BP; Prohászka Z
    Mol Immunol; 2016 Mar; 71():10-22. PubMed ID: 26826462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indications of underdiagnosis of atypical haemolytic uraemic syndrome in a cohort referred to the Coagulation Unit in Malmo, Sweden, for analysis of ADAMTS13 2007-2012.
    Åkesson A; Blom AM; Klintman J; Zetterberg E
    Nephrology (Carlton); 2017 Jul; 22(7):555-561. PubMed ID: 27175932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosomal rearrangement-A rare cause of complement factor I associated atypical haemolytic uraemic syndrome.
    Gleeson PJ; Wilson V; Cox TE; Sharma SD; Smith-Jackson K; Strain L; Lappin D; McHale T; Kavanagh D; Goodship TH
    Immunobiology; 2016 Oct; 221(10):1124-30. PubMed ID: 27268256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The molecular and structural bases for the association of complement C3 mutations with atypical hemolytic uremic syndrome.
    Martínez-Barricarte R; Heurich M; López-Perrote A; Tortajada A; Pinto S; López-Trascasa M; Sánchez-Corral P; Morgan BP; Llorca O; Harris CL; Rodríguez de Córdoba S
    Mol Immunol; 2015 Aug; 66(2):263-73. PubMed ID: 25879158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A missense mutation in factor I (IF) predisposes to atypical haemolytic uraemic syndrome.
    Geelen J; van den Dries K; Roos A; van de Kar N; de Kat Angelino C; Klasen I; Monnens L; van den Heuvel L
    Pediatr Nephrol; 2007 Mar; 22(3):371-5. PubMed ID: 17106690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention and treatment of atypical haemolytic uremic syndrome after kidney transplantation.
    Okumi M; Tanabe K
    Nephrology (Carlton); 2016 Jul; 21 Suppl 1():9-13. PubMed ID: 26988663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical haemolytic uraemic syndrome: a case of rare genetic mutation.
    Sangeetha G; Jayaraj J; Ganesan S; Puttagunta S
    BMJ Case Rep; 2021 Jul; 14(7):. PubMed ID: 34330731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor H and CFHR1 polymorphisms associated with atypical Haemolytic Uraemic Syndrome (aHUS) are differently expressed in Tunisian and in Caucasian populations.
    Leban N; Abarrategui-Garrido C; Fariza-Requejo E; Amiñoso-Carbonero C; Pinto S; Chibani JB; Khelil AH; Sánchez-Corral P
    Int J Immunogenet; 2012 Apr; 39(2):110-3. PubMed ID: 22136554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical haemolytic uraemic syndrome and mutations in complement regulator genes.
    Dragon-Durey MA; Frémeaux-Bacchi V
    Springer Semin Immunopathol; 2005 Nov; 27(3):359-74. PubMed ID: 16189652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement factor H, FHR-3 and FHR-1 variants associate in an extended haplotype conferring increased risk of atypical hemolytic uremic syndrome.
    Bernabéu-Herrero ME; Jiménez-Alcázar M; Anter J; Pinto S; Sánchez Chinchilla D; Garrido S; López-Trascasa M; Rodríguez de Córdoba S; Sánchez-Corral P
    Mol Immunol; 2015 Oct; 67(2 Pt B):276-86. PubMed ID: 26163426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eculizumab in an anephric patient with atypical haemolytic uraemic syndrome and advanced vascular lesions.
    Békássy ZD; Kristoffersson AC; Cronqvist M; Roumenina LT; Rybkine T; Vergoz L; Hue C; Fremeaux-Bacchi V; Karpman D
    Nephrol Dial Transplant; 2013 Nov; 28(11):2899-907. PubMed ID: 24009284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement factor H functional assay may help to monitor atypical haemolytic uraemic syndrome: a pilot study.
    Massart A; Golmarvi S; Hachimi-Idrissi S; Broeders E; Tournay Y; Nortier J; Abramowicz D; Tielemans C; Stordeur P
    Acta Clin Belg; 2013; 68(1):9-14. PubMed ID: 23627188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical hemolytic uremic syndrome: Korean pediatric series.
    Lee JM; Park YS; Lee JH; Park SJ; Shin JI; Park YH; Yoo KH; Cho MH; Kim SY; Kim SH; Namgoong MK; Lee SJ; Lee JH; Cho HY; Han KH; Kang HG; Ha IS; Bae JS; Kim NK; Park WY; Cheong HI
    Pediatr Int; 2015 Jun; 57(3):431-8. PubMed ID: 25443527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic disorders in complement (regulating) genes in patients with atypical haemolytic uraemic syndrome (aHUS).
    Westra D; Volokhina E; van der Heijden E; Vos A; Huigen M; Jansen J; van Kaauwen E; van der Velden T; van de Kar N; van den Heuvel L
    Nephrol Dial Transplant; 2010 Jul; 25(7):2195-202. PubMed ID: 20106822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel CFI mutation in a patient with leukocytoclastic vasculitis may redefine the clinical spectrum of Complement Factor I deficiency.
    Bay JT; Katzenstein TL; Kofoed K; Patel D; Skjoedt MO; Garred P; Schejbel L
    Clin Immunol; 2015 Oct; 160(2):315-8. PubMed ID: 25988862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mutation in factor I that is associated with atypical hemolytic uremic syndrome does not affect the function of factor I in complement regulation.
    Nilsson SC; Karpman D; Vaziri-Sani F; Kristoffersson AC; Salomon R; Provot F; Fremeaux-Bacchi V; Trouw LA; Blom AM
    Mol Immunol; 2007 Mar; 44(8):1835-44. PubMed ID: 17084897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular involvement in atypical haemolytic uraemic syndrome.
    Sampedro López A; Domínguez Moro B; Baltar Martin JM; Garcia Monteavaro C; Barbón García JJ
    Arch Soc Esp Oftalmol; 2017 Dec; 92(12):594-597. PubMed ID: 28347544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.